Redx Pharma
Macclesfield
About Redx Pharma
Redx Pharma is a drug discovery and development company formed in 2010. It is focused on improving the characteristics of existing drug classes to create best-in-class new drugs in the areas of cancer, infection and autoimmune disease. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS. Redx Pharma has three subsidiaries: Redx Oncology Ltd launched in April 2012, Redx Anti-Infectives Ltd launched in April 2013 and Redx Immunology Ltd launched in May 2015.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $103.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2022)
- Ticker: lse:REDX
- Website: redxpharma.com
- Phone: +441625469900
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/redx-pharma-210861 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.